Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone effect on the EC50 of sevoflurane for laryngeal mask insertion in children
ChiCTR2000031812Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone and sevoflurane in inguinal hernia (2 arms), sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoints: heart rate and vital signs. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
oxycodonesevoflurane
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on ChiCTR2000031812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031812.